Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Page 1
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Kimball AB, Jemec GBE, Sayed CJ, Kirby JS, Prens E, Ingram JR, Garg A, Gottlieb AB, Szepietowski JC, Bechara FG, Giamarellos-Bourboulis EJ, Fujita H, Rolleri R, Joshi P, Dokhe P, Muller E, Peterson L, Madden C, Bari M, Zouboulis CC. Kimball AB, et al. Lancet. 2024 Jun 8;403(10443):2504-2519. doi: 10.1016/S0140-6736(24)00101-6. Epub 2024 May 22. Lancet. 2024. PMID: 38795716 Clinical Trial.
Department of Error.
[No authors listed] [No authors listed] Lancet. 2024 May 25;403(10441):2292. doi: 10.1016/S0140-6736(24)01044-4. Lancet. 2024. PMID: 38796208 No abstract available.
Department of Error.
[No authors listed] [No authors listed] Lancet. 2024 May 25;403(10441):2292. doi: 10.1016/S0140-6736(24)01042-0. Lancet. 2024. PMID: 38796210 No abstract available.
Department of Error.
[No authors listed] [No authors listed] Lancet. 2024 May 25;403(10441):2292. doi: 10.1016/S0140-6736(24)01040-7. Lancet. 2024. PMID: 38796209 No abstract available.
Cyberattacks on health care-a growing threat.
The Lancet. The Lancet. Lancet. 2024 May 25;403(10441):2263. doi: 10.1016/S0140-6736(24)01074-2. Lancet. 2024. PMID: 38796195 No abstract available.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Lancet. 2024 Jun 22;403(10445):2695-2708. doi: 10.1016/S0140-6736(24)00821-3. Epub 2024 May 22. Lancet. 2024. PMID: 38795719 Clinical Trial.
Why not eliminate HTLV-1 while eliminating HIV-1?
Maertens GN, Purcell DFJ, Rosadas C, Bradshaw D, Biglione M, Taylor GP, Martin F. Maertens GN, et al. Lancet. 2024 May 25;403(10441):2288-2289. doi: 10.1016/S0140-6736(24)00295-2. Lancet. 2024. PMID: 38796201 No abstract available.
Poetry for rewilding the medical and health humanities.
González-Arias LM, Swain K. González-Arias LM, et al. Lancet. 2024 Aug 10;404(10452):516-517. doi: 10.1016/S0140-6736(24)01077-8. Epub 2024 May 22. Lancet. 2024. PMID: 38795717 No abstract available.
23 results